The growing trend of acquiring small specialized hospitals by tier-1 hospitals is likely to the global thrombectomy devices market in the next four years.
Albany, NY -- (SBWIRE) -- 03/16/2017 -- Global Thrombectomy Devices Market: Overview
Over the past few years, there have been continuous advancement in medical devices technology and developments of healthcare infrastructure leading to better patient outcomes. Thrombectomy devices are increasingly being used in the treatment of acute ischemic stroke for the removal thrombi from the neurovasculature and the market has witnessed interesting product innovations. The rising incidence of peripheral artery diseases and stroke cases has stimulated the demand for thrombectomy procedures and techniques in healthcare institutions including hospitals. Fuelled by these developments, the global thrombectomy devices market is anticipated to witness a steady growth along the forecast period.
The report is prepared with the help of valuable inputs from a wide spectrum of sources including various industry leaders, key manufacturers, business executives, and industry experts. The research gleans through numerous clinical trials focused on the efficacy of different devices and enumerate the factors leading to an increased adoption of these devices compared to other treatment options. The study provides in-depth insights into the changes in regulatory framework in various regions and evaluates their impact on the product innovations brought by manufacturers. The market share and size of key segments in major regions are analyzed.
Request a Brochure of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1190
Global Thrombectomy Devices Market: Trends and Opportunities
The growing trend of acquiring small specialized hospitals by tier-1 hospitals is likely to the global thrombectomy devices market in the next four years. The global thrombectomy devices market is driven by increasing prevalence of chronic diseases, rise in the geriatric population, and soaring demand for minimally invasive procedures. A significant part of ageing population suffers from various cardiovascular diseases stimulating the demand for thrombectomy devices.
Furthermore improvements in healthcare infrastructure and intensive competition among market players have led to various product innovations and technological enhancements in thrombectomy devices. The absence of expertise required to operate these devices and paucity of randomized clinical trials have led to safety and efficacy concerns of these devices. This is likely to hamper the market growth to an extent. Nevertheless, the emergence of various advanced technologies in the manufacture of these devices such as lasers radiation and 3D imaging are expected to open promising opportunities for market players.
Request for TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1190
Global Thrombectomy Devices Market: Regional Outlook
The Americas is a prominent market for thrombectomy devices and is expected to exhibit impressive growth along the forecast period. The regional growth is primarily driven by the increasing incidence of various cardiovascular diseases and the preference of cardiologists for using peripheral vascular procedures.
Asia Pacific is an emerging market for thrombectomy devices and provides promising growth opportunities for the leading market players. Growth witnessed by the market in Asia Pacific is driven by high prevalence of peripheral artery disease (PAD), the launch of technologically advanced devices, rising investment in healthcare infrastructure, and awareness for cardiovascular diseases. Furthermore, favorable government regulations in countries such as India and China are expected to propel the market's growth in the region.
Read Complete Report @ https://www.tmrresearch.com/thrombectomy-devices-market
Global Thrombectomy Devices Market: Competitive Landscape
The global thrombectomy devices market is fairly fragmented with the presence of numerous large small-sized players. Manufacturers are actively offering products advancements and upgrades to gain a stronghold in the market. In addition, mergers and acquisition are adopted by the key market players to consolidate their shares. Major market players operating in this market include Boston Scientific Corporation, Medtronic Plc, Teleflex Incorporated, Penumbra Inc., The Spectranetics Corporation, AngioDynamics, Inc., Terumo Corporation, Johnson and Johnson, Inc., Stryker Corporation, and Vascular Solutions, Inc.